Science Sphere says researchers hope the injection could someday help people hold off weight regain after they stop GLP-1 drugs. No trial details are given.
Recap by typeshit. Post by @science__sphere on Instagram.
The once-daily pill blocks the IL-23 receptor and helped people with moderate to severe ulcerative colitis respond more often than placebo, a new study reports.
Bikman welcomes a new result but argues the likely cause is tirzepatide bringing insulin down rather than the drug slowing aging itself. His view, not a study claim.
Marchione makes the case for pairing GLP-1s with drugs that target amylin, the hormone released after meals that signals fullness to the brain.
Regen says the placebo group saw a 9% drop, while people on retatrutide also lost 31 lb on average and saw systolic blood pressure fall 14 points.
Ellis lists factors she says to weigh before blaming the medication for shedding hair while on a GLP-1 drug.
A short explainer on where Wegovy stands with regulators as a weight loss treatment. Tap through for the details on its approval status.
Loading…